Tumor cell clearance reimagined.
Our mission is to discover, translate, and deliver pioneering curative cell therapies that incorporate multiple forms of tumor clearance into single T cells.
Our technology uniquely integrates anti-tumor capabilities of both the innate and adaptive immune systems into a single T cell.› Exploiting a Natural Immune Process
The CER platform
We are advancing a CER T-cell platform that offers novel approaches for the treatment of both hematologic malignancies and solid tumors.› Therapeutic Potential of Our Platform
Join the quest
Our culture is mission-and innovation-driven towards bringing improved treatment options to patients. We are looking for talented and motivated individuals to join us in our quest.› Careers at CERo
News and events
May 02, 2022CERo Therapeutics’ Multifunctional CER T Cells Synergize with Standard of Care Small Molecule Anti-Tumor Inhibitors Across Hematologic and Solid Tumor Models
Nov 12, 2021CERo Therapeutics’ Novel Chimeric Engulfment Receptor T Cells Exhibit Multifunctional Properties and Enhanced Tumor Killing
Oct 25, 2021CERo to Present at the Society of Immunotherapy for Cancer (SITC)